Navigation Links
Biotech Finishes on a High in August, Burrill Report Says
Date:9/4/2007

t is promoting 'wellness'. The era of personalized medicine is upon us...one that emphasizes predictive and preventive medicine," Burrill continued. "Not surprisingly, diagnostics and nutraceuticals companies have been very successful riding this new paradigm. The Burrill Diagnostics Index, this year to date, for example, is ahead of all other indices and heading into the fall, which is traditionally good for biotech, we expect this trend to continue. In addition, we are seeing companies focused in the personalized medicine space beginning to file for IPO's and test the appetite of investors for this new market opportunity."

FDA and biotech

Over the next few months the FDA is scheduled to pass judgment on at least 12 biotechnology-produced medicines. Success for a majority of these could spell a major surge in the industry's fortunes. "We have already seen a prelude to this with the 42% surge in the value of Onyx Pharmaceuticals' shares in August following positive clinical data," noted Burrill, "Onyx and its partner Bayer AG announced an early end to a trial its drug Nexavar in advanced hepatocellular carcinoma. Having been granted priority review status by the FDA, the drug is on the fast track for regulatory clearance."

Biotech IPO review

It was another slow month for biotech IPOs with only two companies getting their offerings completed. WuXi PharmaTech, a China-based pharmaceutical and biotechnology research and development outsourcing company. The firm raised $212 million offered 15.1 million ADSs, including an over-allotment, at $14 per ADS, a 16.6% premium to the midpoint of its proposed $11 to $13 range. The company's shares closed the month at $26.25 up 87%. Sucampo Pharmaceuticals, an emerging pharmaceutical company focused on the discovery, development and commercialization of drugs based on prostones, a class of compounds derived from functional fatty acids that occur naturally in the human body. The company priced its 3.75 milli
'/>"/>

SOURCE Burrill & Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Biotechnology industry expected to grow into a three billion dollar industry by 2002
2. Biotechnology on the lead
3. Panacea Biotech To Market Anthrax Vaccine
4. Commercialization of Biotech Discoveries, An Encouragement For Researchers
5. Biotech drug causing anemia-EPREX
6. Leading Biotech Companies Are Interested In Acquisition Of Smaller Companies
7. Biologicals Transfer Proposal between US and Indian Biotechnology
8. Finland and India to interact and cooperate in the filed of telemedicine and biotechnology
9. Vical Biotech and NIH jointly develops HIV vaccine
10. Biotechnology Initiatives Planned In Hyderabad
11. Biotech Osiris to go public
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Epigenetics finds applications in a large number of ... developmental biology, and research for metabolic and genetic disorders. ... widely used techniques for the discovery and development of ... is rapidly growing worldwide. In 2012, there were 14.1 ... 32.6 million people living with cancer (within five years ...
(Date:12/24/2014)... (PRWEB) December 24, 2014 Dr. Vu ... the expansion of his practice and med-spa with the ... practice’s growing list of cosmetic treatments and services. , ... into the skin,” says Dr. Ho. “As a result ... such as wrinkles, sun spots, discolorations or blemishes.” , ...
(Date:12/24/2014)... Mike Billings , PT, MS, CEEAA, President ... PT, MBA, GCS, Director of Professional Development to discuss ... of the Improving Medicare Post-Acute Care Transformation Act ... the Infinicast, the two leaders discuss how the IMPACT ... to standardize post-acute assessment data for quality, payment, and ...
(Date:12/24/2014)... new, injectable weight-loss drug has been approved by the ... Tuesday approved Saxenda (liraglutide) for adults who are obese ... least one weight-related health condition, such as high blood ... taking the drug, made by Novo Nordisk, should still ... noted. "Obesity is a public health concern and ...
(Date:12/24/2014)... HealthDay Reporter TUESDAY, Dec. 23, 2014 (HealthDay ... call for giving the cholesterol-lowering drugs known as statins to ... These new standards bring the association in line with the ... recommend giving low- or high-dose statins to all people at ... agree that the decision to start a statin should be ...
Breaking Medicine News(10 mins):Health News:Global Epigenetics Market Was Valued at $413.24 Million in 2014 - New Research Report by MarketsandMarkets 2Health News:Global Epigenetics Market Was Valued at $413.24 Million in 2014 - New Research Report by MarketsandMarkets 3Health News:Dr. Vu Ho Expands Facial Plastic Surgery Practice to Include New Skin Care Treatment 2Health News:Latest Episode of Infinicast Features Infinity Rehab President Discussing IMPACT Act of 2014 and Changes for Post-Acute Therapy Providers in 2015 2Health News:FDA Approves New Weight-Loss Drug 2Health News:FDA Approves New Weight-Loss Drug 3Health News:Nearly All Diabetics Should Be on Cholesterol-Lowering Drugs: Experts 2Health News:Nearly All Diabetics Should Be on Cholesterol-Lowering Drugs: Experts 3
... published in the September Journal of Nuclear Medicine ... role in the evaluation and treatment planning for a ... According to researchers, molecular imaging allows physicians to ... turn, provide patients with personalized care. In addition, molecular ...
... Faith based schools are on the rise in ... values at odds with legislation on equality? Research that ... Leadership published by SAGE shows what happens when school ... consequences for gay students and staff. The UK ...
... cause of cancer deaths worldwide, and the prognosis is ... incidence of one type of lung cancer, adenocarcinoma, has ... the changes in tumor cell biology that result in ... mass of tissue) that have been completely surgically removed ...
... Implementation of staggered radiologist work shifts can expedite the ... to a study in the September issue of the ... ( www.jacr.org ). Radiology practice in the ... it has maximized coverage for imaging such as computed ...
... HealthDay Reporter , TUESDAY, Aug. 31 (HealthDay News) ... strong policy statement directed toward pediatricians, parents and the media ... getting about sex from television, the Internet and other media ... , was published online Aug. 30 and in the September ...
... Health and University of Chicago have found a promising ... of skin and soft-tissue damage caused by USA300, the ... in the United States. By neutralizing a key toxin ... reduce the damaging effects of the infection on skin ...
Cached Medicine News:Health News:Personalized medicine: Molecular imaging predicts treatment success in many cancers 2Health News:Personalized medicine: Molecular imaging predicts treatment success in many cancers 3Health News:Keeping faith -- schools must balance ethos with equality 2Health News:Tumor budding identified as predictor for unfavorable outcome in lung cancer 2Health News:Staggered radiologist work shifts improve patient care, study suggests 2Health News:U.S. Pediatricians Decry Media's Portrayal of Sex 2Health News:U.S. Pediatricians Decry Media's Portrayal of Sex 3Health News:Treatment for S. aureus skin infection works in mouse model 2Health News:Treatment for S. aureus skin infection works in mouse model 3
(Date:12/22/2014)... Dec. 22, 2014 Apnea Sciences ( www.apneasciences.com ... in Aliso Viejo , California.  ... the tremendous growth and worldwide expansion, a new facility ... SnoreRx, the anti snore cure have exceeded our expectations ... "We are now in 23 countries and will be ...
(Date:12/22/2014)... 2014 Research and Markets ( ... "Investment Analysis of the US Medical Device ... http://photos.prnewswire.com/prnh/20130307/600769 ... device sector identifies the key trends and rationale ... and mergers and acquisitions. The study ...
(Date:12/22/2014)... Pa. and STOCKHOLM , ... (publ) (Sobi) and partner Auxilium Pharmaceuticals, Inc. today announced ... (CHMP) of the European Medicines Agency (EMA) has adopted ... clostridium histolyticum) for the treatment of adult men with ... of at least 30 degrees at the start of ...
Breaking Medicine Technology:Investment Analysis of the US Medical Device Sector 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 3Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 4Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 5Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 6
... Texas, Sept. 29 Luminex Corporation (Nasdaq: ... 2010 Prix Galien USA Award for its innovative xTAG® ... named Best Medical Technology at the Prix Galien USA ... 2010, at the American Museum of Natural History in ...
... asked today to make protecting the eyes from ... by increasing the prevalence of UV and eye-health ... as the Surgeon General, and in upcoming healthcare ... the Congressional Vision Caucus, provided the opening remarks ...
Cached Medicine Technology:Luminex Corporation Wins Prestigious 2010 Prix Galien USA Award 2Prevent Blindness America Issues Call-to-Action to Make UV Eye Protection a National Health Priority 2Prevent Blindness America Issues Call-to-Action to Make UV Eye Protection a National Health Priority 3
Disposable Microscissors: Horizontal, Curved...
Disposable Microscissors: Horizontal, Straight...
Disposable Microscissors: Vertical, 90...
Low profile, sharp-tipped scissors with a vertical cutting action. Excellent for peeling and cutting fine epiretinal membranes....
Medicine Products: